JUM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nyberg, D. A.
Right arrow Articles by Souter, V. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nyberg, D. A.
Right arrow Articles by Souter, V. L.

Journal of Ultrasound in Medicine, Vol 20, Issue 6 655-674, Copyright © 2001 by American Institute of Ultrasound in Medicine


JOURNAL ARTICLE

Sonographic markers of fetal trisomies: second trimester

D. A. Nyberg and V. L. Souter
Center for Perinatal Studies, and Department of Radiology, University of Washington Medical Center, Seattle, USA.

OBJECTIVE: Second-trimester sonographic findings of fetal trisomy may include structural abnormalities or sonographic markers of fetal aneuploidy. Unlike structural anomalies, sonographic markers of fetal aneuploidy are insignificant by themselves with regard to outcome, are nonspecific--most frequently seen in normal fetuses, and are often transient. Our objective was to review the second-trimester sonographic findings of the major trisomic conditions, trisomies 13, 18, and 21. METHODS: We reviewed a number of the most commonly accepted markers, including nuchal thickening, hyperechoic bowel, echogenic intracardiac focus, renal pyelectasis, shortened extremities, mild cerebral ventricular dilatation, and choroid plexus cysts. Markers associated with trisomy 21 were emphasized. RESULTS: The sensitivity of sonography for detection of fetal trisomic conditions varies with the type of chromosome abnormality, gestational age at the time of sonography, reasons for referral, criteria for positive sonographic findings, and the quality of the sonography. As an estimate, 1 or more sonographic findings can be identified in approximately 90% of fetuses with trisomy 13, 80% of fetuses with trisomy 18, and 50% to 70% of fetuses with trisomy 21 (Down syndrome). CONCLUSIONS: The presence or absence of sonographic markers can substantially modify the risk of fetal Down syndrome and is the basis of the so-called genetic sonogram. Because maternal biochemical and sonographic markers are largely independent, combined risk estimates will result in even higher detection rates than either alone.


This article has been cited by other articles:


Home page
Obstet GynecolHome page
B. Weisz, P. P. Pandya, A. L. David, W. Huttly, P. Jones, and C. H. Rodeck
Ultrasound Findings After Screening for Down Syndrome Using the Integrated Test
Obstet. Gynecol., May 1, 2007; 109(5): 1046 - 1052.
[Abstract] [Full Text] [PDF]


Home page
J Ultrasound MedHome page
Z. Szigeti, A. Csaba, B. Pete, J. Hajdu, Z. Papp, and C. Papp
Correlation of Prenatal Sonographic Diagnosis and Morphologic Findings of Fetal Autopsy in Fetuses With Trisomy 21
J. Ultrasound Med., January 1, 2007; 26(1): 61 - 68.
[Abstract] [Full Text] [PDF]


Home page
J Ultrasound MedHome page
R. Stressig, S. Kortge-Jung, G. Hickmann, and P. Kozlowski
Prenatal Sonographic Findings in Trisomy 22: Five Case Reports and Review of the Literature
J. Ultrasound Med., November 1, 2005; 24(11): 1547 - 1553.
[Abstract] [Full Text] [PDF]


Home page
J Ultrasound MedHome page
J. R. Wax, A. Cartin, M. G. Pinette, and J. Blackstone
Does the Frequency of Soft Sonographic Aneuploidy Markers Vary by Fetal Sex?
J. Ultrasound Med., August 1, 2005; 24(8): 1059 - 1063.
[Abstract] [Full Text] [PDF]


Home page
J Ultrasound MedHome page
M. M. Taslimi, R. Acosta, J. Chueh, L. Hudgins, K. Hunter, M. L. Druzin, and U. Chitkara
Detection of Sonographic Markers of Fetal Aneuploidy Depends on Maternal and Fetal Characteristics
J. Ultrasound Med., June 1, 2005; 24(6): 811 - 815.
[Abstract] [Full Text] [PDF]


Home page
J Ultrasound MedHome page
M. G. Pinette, J. F.X. Egan, J. R. Wax, J. Blackstone, A. Cartin, and P. A. Benn
Combined Sonographic and Biochemical Markers for Down Syndrome Screening
J. Ultrasound Med., November 1, 2003; 22(11): 1185 - 1190.
[Abstract] [Full Text] [PDF]


Home page
J Ultrasound MedHome page
G. R. DeVore and R. Romero
Genetic Sonography: An Option for Women of Advanced Maternal Age With Negative Triple-Marker Maternal Serum Screening Results
J. Ultrasound Med., November 1, 2003; 22(11): 1191 - 1199.
[Abstract] [Full Text] [PDF]


Home page
J Ultrasound MedHome page
P. Rosati and L. Guariglia
Early Transvaginal Fetal Orbital Measurements: A Screening Tool for Aneuploidy?
J. Ultrasound Med., November 1, 2003; 22(11): 1201 - 1205.
[Abstract] [Full Text] [PDF]


Home page
Obstet GynecolHome page
P. A. Benn, L. M. Kaminsky, J. Ying, A. F. Borgida, and J. F. X. Egan
Combined Second-Trimester Biochemical and Ultrasound Screening for Down Syndrome
Obstet. Gynecol., December 1, 2002; 100(6): 1168 - 1176.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
D. A. Nyberg, J. F. X. Egan, J. F. Rodis, P. A. Benn, R. O. Bahado-Singh, I. Mendilcioglu, J. Copel, R. Smith-Bindman, and J. D. Goldberg
Ultrasound Markers of Fetal Down Syndrome
JAMA, June 13, 2001; 285(22): 2856 - 2858.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the American Institute of Ultrasound in Medicine.